...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZE Slides Up
6
Jan 08, 2019 03:58PM

Thanks Topcoin. The new presentation seems to be focused much more on enhancing existing cancer drugs than previous presentations. Interestingly the TNBC drug that they are starting this new combo trial with is not on the list of drugs that were synergistic with ZEN-3694.

tada

5
Jan 08, 2019 06:06PM
2
Jan 15, 2019 11:35AM
Share
New Message
Please login to post a reply